There are no data that prove that follow-up in an asymptomatic individual will improve survival. Therefore, the rationale is embedded in the clinical opinion of the oncologist and the wishes of the patient. As such the following are suggestions only.
|Years 1 + 2||4 months|
|Years 3 - 5||6 months|
Note: follow-up consists of general exam and pelvirectal exam. Annual Pap smear screening is not required in women who have undergone a hysterectomy as part of their treatment. Women who have not had a hysterectomy should have cervical screening as per BC Cancer recommendations
Other investigations, such as tumor markers, are not required other than for fulfilment of research protocols. Monitoring of CA125 has been shown to result in early intervention with chemotherapy, without any improvement in overall survival but an adverse effect on quality of life37.